findmyKOL

Princy Kumar, MD

Enriched profile

Chief, Division of Infectious Diseases and Tropical Medicine at MedStar Georgetown University Hospital; Senior Associate Dean of Students and Professor of Medicine and Microbiology at Georgetown University School of Medicine · Georgetown University School of Medicine

ORCID↗NPI↗
✓ Full profile
Region🇺🇸 Washington, DC · Northeast · United StatesSpecialtyInfectious DiseaseFocusHIV/AIDS Research and Interventions+4
Active KOLfindmyKOL type: EliteLatest publication2026Online presenceverified 2026Payments2021–2025NIH funding1995–2019

Princy Kumar is Chief, Division of Infectious Diseases and Tropical Medicine at MedStar Georgetown University Hospital; Senior Associate Dean of Students and Professor of Medicine and Microbiology at Georgetown University School of Medicine at Georgetown University School of Medicine. OpenAlex indexes 261 publications with 13,548 citations (h-index 50); ClinicalTrials.gov lists 3 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 10% of Infectious Disease profiles in the findmyKOL directory.

Data verified 17 Oct 2026

Overview

Updated 18 Oct 2026

Princy Kumar is Chief, Division of Infectious Diseases and Tropical Medicine at MedStar Georgetown University Hospital at Georgetown University School of Medicine / MedStar Georgetown University Hospital. The public record shows 261 publications with 13,548 citations (h-index 50), centered on HIV/AIDS Research and Interventions, HIV/AIDS drug development and treatment, HIV Research and Treatment. It also documents an investigator role on 3 registered clinical trials, industry payments reported by 10 companies, 5 NIH-funded awards (1995–2019).

  • Most recent indexed publication: 2026 · Open forum infectious diseases
  • Top research focus: HIV/AIDS Research and Interventions
  • 3 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 10 companies

Generated from the cited public record · current as of 18 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
HIV2 trialsHIV Infections2 trialsVirus Diseases1 trialCOVID-19

Research focus

OpenAlex concept fingerprint
HIV/AIDS Research and InterventionsHIV/AIDS drug development and treatmentHIV Research and TreatmentHIV-related health complications and treatmentsCOVID-19 Clinical Research Studies

Drugs & molecules

across trials, industry payments and publications
Trogarzogeneric · IbalizumabClinical trials—Industry payments5Publications2Sunlencageneric · LenacapavirClinical trials—Industry payments16Publications—Delstrigogeneric · Doravirine / lamivudine / tenofovir disoproxilClinical trials—Industry payments14Publications—Dovatogeneric · Dolutegravir / lamivudineClinical trials—Industry payments6Publications—Symtuzageneric · Cobicistat / darunavir / emtricitabine / tenofovir alafenamideClinical trials—Industry payments4Publications—CabenuvaClinical trials—Industry payments2Publications—Egriftageneric · TesamorelinClinical trials—Industry payments2Publications—Repathageneric · EvolocumabClinical trials—Industry payments2Publications—Apretudegeneric · CabotegravirClinical trials—Industry payments1Publications—Vowstgeneric · Fecal microbiota spores, liveClinical trials—Industry payments1Publications—

Works with

trial sponsors and companies reporting payments
Merck Sharp & Dohme LLCClinical trials—Industry payments71ViiV Healthcare CompanyClinical trials—Industry payments54Gilead Sciences, Inc.Clinical trials—Industry payments30Theratechnologies Inc.Clinical trials—Industry payments8GlaxoSmithKline, LLC.Clinical trials—Industry payments4Janssen Products, LPClinical trials—Industry payments4Janssen Scientific Affairs, LLCClinical trials—Industry payments3Amgen Inc.Clinical trials—Industry payments2Aimmune Therapeutics, Inc.Clinical trials—Industry payments1Georgetown UniversityClinical trials1Industry payments—Merck Sharp & Dohme CorporationClinical trials—Industry payments1TheratechnologiesClinical trials1Industry payments—VGX Pharmaceuticals, LLCClinical trials1Industry payments—

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
261publications

Distinct works indexed by OpenAlex, matched via ORCID; 3 in PubMed.

13,548citations

Total citations across indexed works.

50h-index

Hirsch index (OpenAlex). i10-index 117.

Clinical & industry

trials, payments and federal funding
3clinical trials

Investigator role on registered studies.

View trials ↓
10companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
5NIH grants · 1995–2019

Federally funded research awards.

View funding ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 18 Oct 2026

Listed as an investigator on 3 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 18 Oct 2026

10 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Anti-infectives

    75%
    Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor38.9%
    Tivicay43%Juluca35%Isentress12%Dovato11%
    Part D<11 patients
    Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor23.3%
    Descovy75%Triumeq25%
    Part D<11 patients

    + 2 more classes in this area

  • Cardiovascular

    16.3%
    Statin6.6%
    Atorvastatin Calcium100%
    Part D<11 patients
    ACE inhibitor5.2%
    Lisinopril100%
    Part D<11 patients

    + 1 more class in this area

  • Musculoskeletal

    4.9%
    Xanthine oxidase inhibitor4.9%
    Allopurinol100%
    Part D<11 patients
All 4 therapeutic areas: search, sort and filter.Explore →
Where care is delivered (Part B)63.2% facility · 36.8% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

Updated 18 Oct 2026

5 NIH research awards on record, funded 1995–2019 per NIH RePORTER. The latest:

Publications

Updated 18 Oct 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Network

Updated 18 Oct 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Joseph G. Timpone36Amanda Derryck Castel23Alan E. Greenberg19Anne Kress Monroe18Michael Alan Horberg18Seble Kassaye18José Bordón17Jean‐Michel Molina16SOHAIL R. RANA16Debra Benator16Annick Hebou15Gebeyehu Teferi15Henry Masur14Michael Kharfen14Natella Yurievna Rakhmanina14Lindsey Powers Happ13Christine Katlama13David M. Parenti13Carl W. Dieffenbach13Maria J Jaurretche13Lawrence J. D’Angelo13Michael H. Serlin12Marta Catálfamo12Pedro Enrique Cahn12Moti N. Ramgopal12Edwin DeJesus12Sharon Lynn Walmsley11Deborah A. Goldstein11Pablo Tebas11Olayemi O. Osiyemi11Adriano Lazzarin10Joseph J. Eron10Xiong Jiang10Deepa G. Lazarous10Ronald J. Ellis10David J. Moore10Melanie Thompson10Jai Kumar10Debbie P. Hagins10Ronald D Wilcox9

Online presence

Updated 18 Oct 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/princy-kumar-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 18 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record

Editorial & leadership roles

journal and society appointments
  • Member

    American College of Physicians (MACP)

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →dccfar.gwu.edu ↗

Awards & honors

honors on the public record

Secondary affiliations

appointments beyond the home institution
  • Director

    Clinical Population Sciences Core, DC Center for AIDS Research (DC CFAR)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →dccfar.gwu.edu ↗
  • Principal Investigator

    DC Cohort (NIH-funded longitudinal HIV cohort study)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medstarhealth.org ↗
  • Principal Investigator

    NIH/NIAID AIDS Clinical Trials Group

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →cslide.ctimeetingtech.com ↗

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.